Hong Kong Electric Utilities Stock News

XD Inc. ( HKG:2400 ) shareholders would be excited to see that the share price has had a great month, posting a 26...

Most readers would already be aware that Shanghai Electric Group's (HKG:2727) stock increased significantly by 9.2...

Weimob Inc. ( HKG:2013 ) shareholders would be excited to see that the share price has had a great month, posting a 27...

Wanka Online Inc. ( HKG:1762 ) shareholders would be excited to see that the share price has had a great month, posting...

With a price-to-earnings (or "P/E") ratio of 8.2x Uni-Bio Science Group Limited ( HKG:690 ) may be sending bullish...

The Sheng Tang Holdings Limited ( HKG:8305 ) share price has fared very poorly over the last month, falling by a...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Despite an already strong run, Ingdan, Inc. ( HKG:400 ) shares have been powering on, with a gain of 26% in the last...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

It's not a stretch to say that Starlite Holdings Limited's ( HKG:403 ) price-to-sales (or "P/S") ratio of 0.1x right...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) has drawn fresh investor attention after China’s regulator granted Breakthrough Therapy Designation for sacituzumab tirumotecan with pembrolizumab in first line PD-L1-positive lung cancer, alongside IND approval for SKB105 in advanced solid tumors. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The latest regulatory milestones appear to be feeding into strong momentum, with a 1-day share price return of 2.64%, a 7-day...

For many, the main point of investing is to generate higher returns than the overall market. But in any portfolio...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

As we enter 2026, Asian markets are capturing global attention with their robust performance, driven by optimism in the tech sector and a resurgence in consumer spending. Amidst this momentum, investors are increasingly looking for value stocks—those trading below their estimated worth—that could offer potential opportunities within this thriving economic landscape.

Shanghai Qingpu Fire-Fighting Equipment Co., Ltd. ( HKG:8115 ) shares have had a horrible month, losing 27% after a...

As we enter 2026, the Asian markets are capturing global attention with strong performances, particularly in the small-cap segment, echoing trends seen in other regions where small-cap and value shares have outpaced their larger counterparts. In this dynamic environment, identifying promising stocks involves looking for those with solid fundamentals and growth potential that can thrive amid current economic indicators and evolving market sentiments.

As we enter January 2026, Asian markets are experiencing a notable upswing, with equities advancing and indices reaching new heights amid global optimism. In this context, penny stocks—typically representing smaller or newer companies—continue to capture investor interest due to their potential for growth at lower price points. While the term "penny stocks" may seem outdated, these investments can still offer value when supported by strong financials and solid fundamentals, presenting an...

Key Insights The considerable ownership by private companies in Kerry Properties indicates that they collectively have...

Those holding CNNC International Limited ( HKG:2302 ) shares would be relieved that the share price has rebounded 25...

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

EQRx, based in Cambridge, USA, previously reported new clinical trial data for its lung cancer candidate sugemalimab, a monoclonal antibody developed in collaboration with CStone Pharmaceuticals, with plans to present the findings at the World Conference on Lung Cancer 2021. The therapy’s design to mirror a naturally occurring antibody, potentially lowering immunogenicity and toxicities, highlights CStone’s exposure to differentiated immuno-oncology innovation through this partnership. We’ll...

Lingbao Gold Group (SEHK:3330) has issued new full year 2025 earnings guidance, indicating higher revenue and a much larger net profit range, supported by increased gold output, efficiency gains and favorable gold prices. See our latest analysis for Lingbao Gold Group. The guidance arrives after a sharp run in Lingbao Gold Group’s shares, with a 1-month share price return of 15.14% and a very large 1-year total shareholder return, suggesting that momentum has been building as investors...

Morimatsu International Holdings (SEHK:2155) has reported the death of independent non executive director Mr. Kanno Shinichiro, leaving the company temporarily out of compliance with several Hong Kong Stock Exchange board composition rules. See our latest analysis for Morimatsu International Holdings. The news comes after a strong run in the shares, with the latest share price at HK$10.9 and a 30 day share price return of 25.58%. The 1 year total shareholder return of 162.87% signals powerful...